Cerebral capillary hemorrhage is called cerebral microhemorrhage and the main treatments are symptomatic supportive therapy and blood pressure control therapy.
Cerebral microbleeds are small, acute, subacute, or chronic punctate hemorrhages detected using magnetic resonance imaging (MRI), which is sensitive to iron deposition. They are commonly detected by T2 gradient echo sequence of MRI and magnetic susceptibility weighted imaging. The following disorders are associated with cerebral microbleeds. (1) Cerebral amyloid angiopathy: microhemorrhages occur mainly in the cerebral cortex while the deep gray matter and brainstem are preserved. There is no specific drug for its treatment, and it is treated with symptomatic supportive therapy, and if cognitive impairment occurs, it can be treated symptomatically with cognitive improvement drugs such as donepezil.
(2) Hypertension: It will lead to the hardening of small cortical and subcortical arteries, and microhemorrhages are likely to occur in the deep gray matter and brain stem. Its treatment is regular use of antihypertensive drugs to control blood pressure, such as Irbesartan and Amlodipine benzenesulfonate.
(3) Genetically related: for example, autosomal dominant cerebral arteriopathy with subcortical infarction and white matter encephalopathy, microhemorrhage is mainly seen in the thalamus, but may also involve the deep gray matter and subcortical white matter, brainstem, cerebellum and corticomedullary junction, etc. There is no effective treatment. There is no effective treatment, mainly symptomatic supportive therapy, such as cytarabine and other drugs to promote brain cell metabolism.
After cerebral capillary hemorrhage, the cause of the disease should be clarified and appropriate treatment should be carried out to avoid aggravation of the disease.
Drugs should be used under the guidance of a physician, do not take on your own.